focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Blame it on Italy, or maybe don't...

Tue, 27th Mar 2018 16:13

* European stocks rebound, up more than 1 pct * Wall Street up only slightly after Monday's rally * Reports of U.S.-China trade talks boost risk assets March 27 - Welcome to the home for real-time coverage of European equity markets brought toyou by Reuters stocks reporters and anchored today by Helen Reid. Reach her on Messenger toshare your thoughts on market moves: helen.reid.thomsonreuters.com@reuters.net BLAME IT ON ITALY, OR MAYBE DON'T...(1507 GMT) The ability of investors to shrug off anything from nuclear threats to trade war fearscontinues to bemuse analysts and among their subject of bafflement is the political situation inItaly. "About a month after the parliamentary election, investors are relatively relaxed about thecontinued existence of the Euro. This is astonishing, because the election result would havegiven every reason to believe that Italy is more likely to withdraw", wrote Sentix this morning. The behavioural finance specialist's Euro Break-up Index shows investors don't believe thevictory of the anti-establishment 5-star movement and Italy's far-right League makes the countryany more likely to breaking up from the euro zone. "Given the recent moderation in the message of M5S and Lega, we remainsceptical about any scenario involving a re-consideration of Italian membership in the EU andthe euro or a radical revision of Italy fiscal priorities", UBS analysts said this morning,noting the euro had "been little affected by post-election uncertainty". A number of economists however are blaming the results of the March 4 vote for the fall inEuro zone sentiment in March (see) published today. "The recent falls in economic confidence signal a loss of momentum at the start of 2018 andare consistent with a higher political uncertainty in post-election Italy and the spectre ofrising protectionism", wrote Oxford Economics. While Milan stocks have slightly underperformed other European bourses these last two daysafter the possibility of a coalition government between the 5-Star Movement and the League wasevoked over the weekend, the FTSE MIB has clearly outperformed since the beginning of the yearand even since the election. (Julien Ponthus) ***** TECH LEADERS MOST VULNERABLE TO RISING TRADE BARRIERS (1450 GMT) Tech stocks are top of the charts today with chipmakers ams , Infineon,STMicro in the lead. The index is on track for its best day in three weeksafter a difficult time for the sector hit by trade worries. But semiconductor stocks are also the most likely to be impacted by rising protectionism,according to Citi analysts who've mulled this question today despite the apparent detente innegotiations between the U.S. and China. They reckon it's "highly likely" the semiconductor sub-sector would be targeted as part ofU.S. tariffs, given its strategic importance and contribution to the U.S. trade deficit. Rising protectionism could negatively impact chip demand by: - slowing GDP growth (near-term) - disrupting supply chains (medium-term) - reducing consumer spending as the cost of tariffs is passed on (long-term) It could also throw a spanner in the works for cross-border M&A in semiconductors. Other subsectors such as communication technology, enterprise software and IT services, arelikely to be less impacted, Citi adds. They see ASML as the most resilient stockrelative to chipmaker peers in this climate. (Helen Reid) ***** A TALE OF TWO STOCKS (1414 GMT) Today is probably an opportune time to take a look at two stocks which perhaps exemplify thestruggles facing retailers today: H&M, currently the biggest STOXX faller after its Q1results, and Inditex which owns Zara. All you really need to do is look at the how the shares have diverged since around 2010 (seechart below). And even with all of the obstacles and uncertainty facing retailers today,investors are still upbeat on Inditex's prospects. "(Inditex has) managed to ride this disruption in the industry extremely well, despite beingquite late to it," Alistair Wittet, European equities analyst and portfolio manager at Comgest,said. Inditex is Wittet's second-biggest position in the Comgest Growth Europe ex-UK fund. Wittet pointed to Inditex realising that while physical stores still have a role to play inthe synergy with online, this is as an advertising front for the retailer where the emphasis ison the customer experience, an example of which is the introduction of augmented realitydisplays in Zara stores from April. "H&M actually went online before Inditex, but their business model wasn't set up for it, andthey were very slow ... in everything else," Wittet added. (Kit Rees) ***** SOLID EUROZONE GROWTH OUTLOOK? "LARGELY DISCOUNTED" (1312 GMT) European shares may be rising sharply and the rebound is strong enough to help investorsturn a blind eye on yet more weaker than expected euro zone data and continue to play catch upwith Wall Street. Today's disappointing data however further underscores how the scope forEuropean macro to outperform high expectations has become pretty limited, as reflected by therecent drop further into negative territory of the Citi Economic Surprise indexfollowing a very long performance in positive ground. "The inevitable happened: confidence and activity indices edged down from their record highlevels in February and dragged the Economic Surprise index into negative territory. Such adecline simply reflects the fact that the (still positive!) growth outlook for the Eurozone isnow largely expected," say analysts at SYZ Wealth Management. In this chart you can see how euro zone stocks have suffered from the absence of economicsurprises. (Danilo Masoni) **** MIDDAY SNAPSHOT: DEAD CAT BOUNCE? (1149 GMT) "Equities are extending their rebound as investors breath a collective sigh of relief that aglobal trade war looks to be off the menu", Mike van Dulken, head of research at Accendo Marketsjust wrote to his clients. The STOXX 600 is currently up 1.4 percent while S&P futures areclimbing 0.5 percent. Here's what the European stock market looked like at 1126 GMT: While investors ignored weak Euro Zone economic data (see here:), they areclearly getting confident a full-blown trade war is off the cards. The sensitivity of the issueis such however that today's rally could only be a temporary respite. As van Dulken says: "There are a lot of risks that financial markets have shrugged off overthe last couple of years, to the amazement at times of investors, but the prospect of a tradewar is clearly not one of these. Ahead of the European open this morning however, a number of analysts were wondering whetherWall Street's surge on Monday would last. "Another dead cat bounce?" said Rabobank, arguing that "it is perhaps too early to declarethat the bulls have regained the initiative – after all rallies do not go in a straight line,which also applies to sell-off". "The situation is still very sensitive and we do think that the relief rally in the equitymarket is purely due to the heavy sell-off. It is more of a dead cat bounce than anything else",wrote Naeem Aslam of ThinkMarkets before market open. As noted in earlier posts, big investment houses, such as Goldman Sachs (see here) are still optimistic on the general trend. "We think that the temptation to ‘buy on the dip’ is likely to limit market setbacks createdby nervous reactions to events", Barclays analysts also wrote this morning. (Julien Ponthus) ***** A "HEALTHIER RALLY" AHEAD? (1052 GMT) We've had a "healthy" correction, but could the recent sell-off lead to a "healthy" rally? Barclays' equity derivative strategists see the possibility of a trade war keeping themarket on edge, which they say would allow some of the "excessive exuberance" to abate. Theypoint to a cooling in equity market valuations since the recent sell-off (see Barclays' chartsbelow) and sentiment among retail investors moderating. "In one sense, we view this as a healthy development, given it would provide an outlet forsome of the excess exuberance," say Barclays' strategists in a note. One thing to watch is how fast volatility normalises. Barclays notes that if this isgradual, it would be a sign that market sentiment was cautious and herald a return to "the“normal” grinding rally". "If equities do not recover sharply, we believe valuations have a better chance ofnormalising, which would set the stage for a healthier subsequent rally," Barclays concludes. (Kit Rees) ***** KEEPING TABS ON THE S&P'S 200-DAY MOVING AVERAGE (1005 GMT) Investors are increasingly looking at the S&P 500's 200-day moving average,especially after the two big sell-offs that roiled markets this year saw the bears surrender tothe bulls just when the U.S. benchmark index hit that level. The S&P fell more than 6 percent last week to end a tick above the 200-day average, but onMonday it staged a powerful bounce, indicating how crucial that level has become for the market. Going forward, any breach below it may well be seen as a negative signal and JCI Capitalfund manager Alessandro Balsotti believes that from now on investors will be monitoring it evenmore "religiously". And what about Europe? Well it's a different story: the STOXX 600 has been tradingbelow the 200-day average since early February. (Danilo Masoni) ***** SHARES SHRUG OFF WEAK EUROPEAN DATA BUT "PEAK GROWTH" NARRATIVE BUILDS (0950 GMT) Economic sentiment in the euro zone slipped for a third month in a row in March as managersin manufacturing, services and retail became slightly less optimistic, European Commission datajust showed. But stocks are taking this in their stride and have even accelerated their risefrom 1.2 percent to 1.5 percent since the data was published. A whole bunch of research this morning ahead of the publication noted, like DNB's dailynote, that "Eurozone macro data surprises have been more negative than positive recently" andthat "growth is strong, but no longer accelerating". For CMC Markets, "the beginning of possible micro fissures in the European growth story"and "momentum indicators ... flashing warning signs" may be an explanation as to why Europeanmarkets are having a hard time keeping up with their U.S. counterparts. In a strategy note on European equities this morning, HSBC said that its "economics team'sview of GDP growth momentum fading through the course of this year" backed investing in longerduration fixed income and in stocks with higher dividend yield for their "defensive attributes". On the trading floor however the consensus seems to be that the euro zone's economic healthstill backs an optimistic view of its shares. There can be "a lot of noise in macro data in thenear-term", Chris Dyer, director of global equity at Eaton Vance just told us. "Generally we think the European economy is on a good footing", Dyer, who is overweightEuropean equities, said, adding that the weakness in economic data will only become a concern ifit continues. Here's a chart by DNB showing the loss of growth momentum in Europe: (Helen Reid and Julien Ponthus) ***** OPENING SNAPSHOT: EUROPEAN STOCKS BOUNCE (0727 GMT) European shares are joining in a global relief rally in risk assets as trade tensions ease.Sectors which were hit hardest over the past few sessions, such as autos, basicresources and tech, are the biggest gainers early on. The biggest individual mover so far is France's Casino, which has jumped around 6percent after its Monoprix chain agreed to sell products via Amazon. This shows just how crucialit is for companies to demonstrate that they are keeping up with the times and exploring onlineopportunities. Regarding the spreadbetters and ESMA's restrictions on CFDs, it's a mixed bag following adecidedly negative start, with IG down slightly but both CMC and Plus500 making gains. Here's your opening snapshot: (Kit Rees) ***** WHAT'S ON THE RADAR FOR THE OPEN (0649 GMT) European stocks are set to surge with futures climbing 1.4 to 2.2 percent across the majorbenchmarks, riding the wave of rising equities worldwide after Wall Street indices had theirstrongest day in years as investors bet on a trade war détente. Retail stocks will be ones to watch after French supermarket group Casino struck a deal withAmazon to make groceries from its Monoprix chain of stores available on Amazon’s Prime Nowservice to Parisian customers this year. The partnership extends Amazon’s reach into the European grocery market, and while Casinoshares are seen rising 3 to 5 percent, the news could shake investors’ confidence in retailnames that are more behind the curve. In M&A news, GlaxoSmithKline shares are expected to rise 3 to 4 percent after the pharmacompany announced it was buying out Novartis’ stake in their consumer healthcare joint venturefor $13 billion. Novartis is seen up 1 percent. Another corporate break-up story from Akzo Nobel which is to sell its Specialty Chemicalsbusiness for $12.6 billion to U.S. private equity firm Carlyle Group and Singapore’s GIC –ending the simplification effort which began as the paint maker sought to evade a takeover fromPPG in April 2017. Its shares are set to rise 2 to 4 percent. Spreadbetters such as IG Group, CMC Markets and Plus500 are seen down 2 percent premarketafter a move from European markets regulator ESMA to crack down on contract-for-difference (CFD)trades offered to retail clients. (Helen Reid) ***** MORNING HEADLINE ROUND-UP (0637 GMT) Here's a round-up of key headlines for European companies this morning - note the news thatCasino's Monoprix is going to be teaming up with Amazon to sell groceries on Prime Nowin Paris. Casino's shares are seen up as much as 5 percent premarket. GSK buys Novartis stake in consumer healthcare venture for $13 bln H&M Q1 pretax dives in line with expectations, flags more markdowns Deutsche Bank seeks to replace CEO with Goldman executive -report Amazon wins grocery foothold in France through Monoprix deal Galliford Try to raise 158 mln stg to cover Carillion project costs Nordex sees lower sales, margins as wind industry tightens Akzo Nobel to sell unit to Carlyle, GIC for 10.1 bln euros (Kit Rees) ***** EUROPEAN STOCK FUTURES SURGE (0610 GMT) Futures for the major European stock markets have opened sharply higher, rising 1.1 to 1.8percent with the DAX in the lead, as investors place bets on a strong bounce at the open. Meanwhile analysts are still mulling what caused the late-afternoon slump in sharesyesterday. Here's Peel Hunt strategist Ian Williams: "The trigger was not immediately obvious with neither further strength in the euro, or thelatest wave of Russian diplomatic expulsions, especially convincing reasons for such a move. Amore worrying interpretation is that investors may be taking advantage of even the most modestof rallies to lighten their equity exposure." If Williams is right we may see a volatile session today as well - but for the moment allsigns are pointing to a strong rebound for the European market. (Helen Reid) ***** BULLS TO KEEP THE UPPER HAND (0548 GMT) Goldman Sachs' Bear/Bull indicator is above 70%, a level normally associated with animminent bear market (see below). But the GS team led by Peter Oppenheimer reckons relativelyattractive equity valuations will protect markets from a big drawdown, at least for now. There's also a wide spread in the underlying variables behind the indicator: very low levelsof unemployment and strong growth momentum are normally accompanied with "tighter monetarypolicy, a flatter yield curve and rising core inflation," notes GS. "But these remain subduedand without these risks rising, the prospect of a recession and 'cyclical' bear market is low." Valuation meanwhile is becoming less of a risk, they add - the forward consensus PE for theMSCI AC World is back to its 1990 average and below its average excluding Tech stocks. Highvaluations are mostly confined to the U.S. market. Furthermore, free cash flow yields have increased along with P/E ratios, and the total cashreturn from equities (dividend yield + buyback yield) has risen in most markets. So the overall message from GS is: don't panic! The bulls will prevail, at least for now... (Helen Reid) ***** MORNING CALL: EUROPEAN STOCKS TO BOUNCE BACK STRONGLY(0520 GMT) Good morning and welcome to Live Markets. Risk appetite is back! European stocks are called to open strongly higher today after a weakclose yesterday. They're being pushed up by the equities rally on Wall Street and in Asiaovernight greeting news that the U.S. and China are holding behind-the-scenes trade talks. White House officials are asking China to cut tariffs on imported cars, allow foreignmajority ownership of financial services firms and buy more U.S.-made semiconductors, accordingto a person familiar with the discussions. Asian shares bounced back overnight with the Nikkei up 1.7 percent and Chinese blue-chipsgaining 1.2 percent. The gains came after a stellar session on Wall Street with the Dowdelivering its third-biggest point gain ever, jumping 2.8 percent, while the S&P 500 gained 2.7percent and the Nasdaq surged up 3.3 percent. A negative currency effect could weigh on European stocks today, though, with the euro stillnear the six-week high against the dollar it touched yesterday. It had its biggest one-daypercentage gain since June 2017 yesterday. Spreadbetters call the DAX 183 points higher at 11,971, the CAC 40 up 60 points at 5,127,and the FTSE 100 78 points higher at 6,966. (Helen Reid) ***** (Reporting by Helen Reid, Danilo Masoni, Julien Ponthus and Kit Rees)
More News
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more
24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
Loungers PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Close Brothers Group PLCTrading Statement
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Strip Tinning Holdings PLCFull Year Results
Whitbread PLCFull Year Results
Wednesday 1 May 
Computacenter PLCTrading Statement
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

Read more
24 Apr 2024 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jemperli, when used in combination with chemotherapy.

Read more
17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea.

Read more
17 Apr 2024 07:11

GSK posts promising results from gonorrhoea treatment trial

(Sharecast News) - GSK unveiled encouraging outcomes from a pivotal phase three trial on Wednesday, on the potential of gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea (GC), amid escalating resistance to current therapies.

Read more
16 Apr 2024 09:17

GSK meningococcal vaccine accepted by US FDA for review

(Sharecast News) - GSK announced on Tuesday that its five-in-one meningococcal ABCWY (MenABCWY) vaccine candidate had been accepted for regulatory review by the US Food and Drug Administration (FDA).

Read more
16 Apr 2024 08:59

GSK's latest meningitis vaccine accepted for review by US regulator

(Alliance News) - GSK PLC on Tuesday said it has made progress in the development of its newest candidate, which combines the strengths of two other vaccines in its portfolio into one bacteria-fighting inoculation.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
9 Apr 2024 11:45

Pfizer RSV shot meets goals in trial of high-risk adults under age 60

April 9 (Reuters) - Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60 similar to that in older adults, for whom the shot is already approved.

Read more
8 Apr 2024 09:13

LONDON BROKER RATINGS: Wizz Air raised; HSBC cuts Rentokil to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
4 Apr 2024 13:08

UK dividends calendar - next 7 days

Friday 5 April 
BBGI Global Infrastructure SAdividend payment date
Molten Ventures PLCdividend payment date
Pennon Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
Regional REIT Ltddividend payment date
Rights & Issues Investment Trust PLCdividend payment date
Sylvania Platinum Ltddividend payment date
Titon Holdings PLCdividend payment date
Triple Point Energy Transition PLCdividend payment date
Monday 8 April 
Alumasc Group PLCdividend payment date
LondonMetric Property PLCdividend payment date
Redrow PLCdividend payment date
Tuesday 9 April 
CT Global Managed Portfolio Trust PLCdividend payment date
Downing Strategic Micro-Cap Investment Trust PLCdividend payment date
Dunelm Group PLCspecial dividend payment date
Hays PLCdividend payment date
Renishaw PLCdividend payment date
Safestore Holdings PLCdividend payment date
Wednesday 10 April 
Assura PLCdividend payment date
Primorus Investments PLCspecial dividend payment date
Wilmington PLCdividend payment date
Thursday 11 April 
Amedeo Air Four Plus Ltdex-dividend payment date
Athelney Trust PLCdividend payment date
Aviva PLCex-dividend payment date
Balanced Commercial Property Trust Ltdex-dividend payment date
Barratt Developments PLCex-dividend payment date
Begbies Traynor Group PLCex-dividend payment date
Bioventix PLCex-dividend payment date
Blackfinch Spring VCT PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
Caledonia Mining Corpex-dividend payment date
Capital & Regional PLCex-dividend payment date
Chesnara PLCex-dividend payment date
Colefax Group PLCdividend payment date
CT Private Equity Trust PLCex-dividend payment date
Downing Strategic Micro-Cap Investements Trust PLCex-dividend payment date
Driver Group PLCdividend payment date
F&C Investment Trust PLCex-dividend payment date
Foxtons Group PLCex-dividend payment date
Grafton Group PLCex-dividend payment date
GSK PLCdividend payment date
Harbour Energy PLCex-dividend payment date
Hargreaves Services PLCdividend payment date
Howden Joinery Group PLCex-dividend payment date
Hunting PLCex-dividend payment date
i3 Energy PLCex-dividend payment date
International Personal Finance PLCex-dividend payment date
International Public Partnerships Ltdex-dividend payment date
ITV PLCex-dividend payment date
Johnson Service Group PLCex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
JPMorgan Japan Small Cap Growth & Income PLCex-dividend payment date
Just Group PLCex-dividend payment date
Kenmare Resources PLCex-dividend payment date
Kerry Group PLCex-dividend payment date
Kings Arms Yard VCT PLCex-dividend payment date
Law Debenture Corp PLCdividend payment date
Lloyds Banking Group PLCex-dividend payment date
Lowland Investment Cos PLCex-dividend payment date
Luceco PLCex-dividend payment date
Man Group PLCex-dividend payment date
Manchester & London Investement Trust PLCex-dividend payment date
Marble Point Loan Financing Ltdex-dividend payment date
Mercantile Investment Trust PLCex-dividend payment date
Mobius Investment Trust PLCex-dividend payment date
MTI Wireless Edge Ltddividend payment date
North American Income Trust PLCex-dividend payment date
Northamber PLCex-dividend payment date
Octopus Apollo VCT PLCex-dividend payment date
Phoenix Group Holdings PLCex-dividend payment date
Reckitt Benckiser Group PLCex-dividend payment date
Ricardo PLCdividend payment date
Savills PLCex-dividend payment date
Schroder Asian Total Return Investment Cos PLCex-dividend payment date
Schroder European Real Estate Investment Trust PLCex-dividend payment date
Scottish American Investment Cos PLCdividend payment date
Smurfit Kappa Group PLCex-dividend payment date
Softcat PLCex-dividend payment date
Somero Enterprises Incex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Synectics PLCex-dividend payment date
TP ICAP Group PLCex-dividend payment date
Trifast PLCdividend payment date
TT Electronics PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.